Literature DB >> 24820863

Paroxysmal itch caused by gain-of-function Nav1.7 mutation.

Grazia Devigili1, Roberto Eleopra, Tiziana Pierro, Raffaella Lombardi, Sara Rinaldo, Christian Lettieri, Catharina G Faber, Ingemar S J Merkies, Stephen G Waxman, Giuseppe Lauria.   

Abstract

Itch is a common experience. It can occur in the course of systemic diseases and can be a manifestation of allergies or a consequence of diseases affecting the somatosensory pathway. We describe a kindred characterized by paroxysmal itch caused by a variant in SCN9A gene encoding for the Nav1.7 sodium channel. Patients underwent clinical and somatosensory profile assessment by quantitative sensory testing, nerve conduction study, autonomic cardiovascular reflex, and sympathetic skin response examination, skin biopsy with quantification of intraepidermal nerve fiber density, and SCN9A mutational analysis. The index patient, her mother, and a sister presented with a stereotypical clinical picture characterized by paroxysmal itch attacks involving the shoulders, upper back, and upper limbs, followed by transient burning pain, and triggered by environmental warmth, hot drinks, and spicy food. Somatosensory profile assessment demonstrated a remarkably identical pattern of increased cold and pain thresholds and paradoxical heat sensation. Autonomic tests were negative, whereas skin biopsy revealed decreased intraepidermal nerve fiber density in 2 of the 3 patients. All affected members harbored the 2215A>G I739V substitution in exon 13 of SCN9A gene. Pregabalin treatment reduced itch intensity and attack frequency in all patients. The co-segregation of the I739V variant in the affected members of the family provides evidence, for the first time, that paroxysmal itch can be related to a mutation in sodium channel gene.
Copyright © 2014 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Burning pain; Itch; Neuropathic pain; Paroxysmal; SCN9A; Small nerve fiber; Sodium channels

Mesh:

Substances:

Year:  2014        PMID: 24820863     DOI: 10.1016/j.pain.2014.05.006

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  26 in total

Review 1.  Neuroimmune interactions in itch: Do chronic itch, chronic pain, and chronic cough share similar mechanisms?

Authors:  Ru-Rong Ji
Journal:  Pulm Pharmacol Ther       Date:  2015-09-06       Impact factor: 3.410

2.  A disease mutation reveals a role for NaV1.9 in acute itch.

Authors:  Juan Salvatierra; Marcelo Diaz-Bustamante; James Meixiong; Elaine Tierney; Xinzhong Dong; Frank Bosmans
Journal:  J Clin Invest       Date:  2018-11-05       Impact factor: 14.808

3.  Sulfonamides as Selective NaV1.7 Inhibitors: Optimizing Potency and Pharmacokinetics to Enable in Vivo Target Engagement.

Authors:  Isaac E Marx; Thomas A Dineen; Jessica Able; Christiane Bode; Howard Bregman; Margaret Chu-Moyer; Erin F DiMauro; Bingfan Du; Robert S Foti; Robert T Fremeau; Hua Gao; Hakan Gunaydin; Brian E Hall; Liyue Huang; Thomas Kornecook; Charles R Kreiman; Daniel S La; Joseph Ligutti; Min-Hwa Jasmine Lin; Dong Liu; Jeff S McDermott; Bryan D Moyer; Emily A Peterson; Jonathan T Roberts; Paul Rose; Jean Wang; Beth D Youngblood; Violeta Yu; Matthew M Weiss
Journal:  ACS Med Chem Lett       Date:  2016-09-21       Impact factor: 4.345

4.  Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent NaV1.7 inhibitors.

Authors:  Brian A Sparling; S Yi; J Able; H Bregman; Erin F DiMauro; R S Foti; H Gao; A Guzman-Perez; H Huang; M Jarosh; T Kornecook; J Ligutti; B C Milgram; B D Moyer; B Youngblood; V L Yu; M M Weiss
Journal:  Medchemcomm       Date:  2016-12-02       Impact factor: 3.597

Review 5.  The role of sodium channels in painful diabetic and idiopathic neuropathy.

Authors:  Giuseppe Lauria; Dan Ziegler; Rayaz Malik; Ingemar S J Merkies; Stephen G Waxman; Catharina G Faber
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

Review 6.  [Neuropathic pruritus-Evidence-based treatment recommendations].

Authors:  Panoraia Baka; Frank Birklein
Journal:  Nervenarzt       Date:  2022-08-11       Impact factor: 1.297

Review 7.  Inhibition of NaV1.7: the possibility of ideal analgesics.

Authors:  Yutaka Kitano; Tsuyoshi Shinozuka
Journal:  RSC Med Chem       Date:  2022-08-01

Review 8.  Itch and neuropathic itch.

Authors:  Junichi Hachisuka; Michael C Chiang; Sarah E Ross
Journal:  Pain       Date:  2018-03       Impact factor: 6.961

9.  FGF13 Is Required for Histamine-Induced Itch Sensation by Interaction with NaV1.7.

Authors:  Fei Dong; Haixiang Shi; Liu Yang; Huaqing Xue; Manyi Wei; Yan-Qing Zhong; Lan Bao; Xu Zhang
Journal:  J Neurosci       Date:  2020-11-10       Impact factor: 6.167

Review 10.  Common and discrete mechanisms underlying chronic pain and itch: peripheral and central sensitization.

Authors:  Chengjin Li; Hee Jin Kim; Seung Keun Back; Heung Sik Na
Journal:  Pflugers Arch       Date:  2021-07-10       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.